v3.26.1
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
No Par, Common Stock
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period at Dec. 31, 2024 $ 21,525 $ 98,178 $ (63,153) $ (13,500)
Balance at beginning of period (in shares) at Dec. 31, 2024   1,746,125    
Balance at end of period at Mar. 31, 2025 25,585 $ 100,117 (62,631) (11,901)
Balance at ending of period (in shares) at Mar. 31, 2025   1,746,125    
Balance at beginning of period at Dec. 31, 2024 21,525 $ 98,178 (63,153) (13,500)
Balance at beginning of period (in shares) at Dec. 31, 2024   1,746,125    
Net income (loss) 2,573   2,573  
Issuance of warrants 1,924 $ 1,924    
Stock-based compensation expense 30 30    
Other comprehensive income (loss) 2,156     2,156
Balance at end of period at Jun. 30, 2025 28,208 $ 100,132 (60,580) (11,344)
Balance at ending of period (in shares) at Jun. 30, 2025   1,746,125    
Balance at beginning of period at Dec. 31, 2024 21,525 $ 98,178 (63,153) (13,500)
Balance at beginning of period (in shares) at Dec. 31, 2024   1,746,125    
Balance at end of period at Dec. 31, 2025 8,966 $ 100,158 (81,591) (9,601)
Balance at ending of period (in shares) at Dec. 31, 2025   1,746,125    
Balance at beginning of period at Mar. 31, 2025 25,585 $ 100,117 (62,631) (11,901)
Balance at beginning of period (in shares) at Mar. 31, 2025   1,746,125    
Net income (loss) 2,051      
Stock-based compensation expense 15 $ 15    
Other comprehensive income (loss) 557     557
Balance at end of period at Jun. 30, 2025 28,208 $ 100,132 (60,580) (11,344)
Balance at ending of period (in shares) at Jun. 30, 2025   1,746,125    
Balance at beginning of period at Dec. 31, 2025 8,966 $ 100,158 (81,591) (9,601)
Balance at beginning of period (in shares) at Dec. 31, 2025   1,746,125    
Net income (loss) 5,158   5,158  
Issuance of common stock 14,000 $ 14,000    
Issuance of common stock, Shares   2,000,000    
Common stock issuance costs (261) $ (261)    
Repurchase of common stock, share   (33)    
Repurchase of common stock, value (1) $ (1)    
Stock-based compensation expense 26 26    
Other comprehensive income (loss) (143)     (143)
Balance at end of period at Jun. 30, 2026 27,745 $ 113,922 (76,433) (9,744)
Balance at ending of period (in shares) at Jun. 30, 2026   3,746,092    
Balance at beginning of period at Mar. 31, 2026 25,190 $ 113,919 (78,969) (9,760)
Balance at beginning of period (in shares) at Mar. 31, 2026   3,746,125    
Net income (loss) 2,536   2,536  
Common stock issuance costs (9) $ (9)    
Repurchase of common stock, share   (33)    
Repurchase of common stock, value (1) $ (1)    
Stock-based compensation expense 13 13    
Other comprehensive income (loss) 16     16
Balance at end of period at Jun. 30, 2026 $ 27,745 $ 113,922 $ (76,433) $ (9,744)
Balance at ending of period (in shares) at Jun. 30, 2026   3,746,092